By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
It has been a mixed year for Evommune, Inc. insiders: $70.2 million bought by six people and $2.3 million sold by six, so more buying than selling overall.
The largest purchase came from LSP 7 Cooperative UA (10% Owner), about $25 million. C-suite participation is part of the picture here.
Looking at the quarterly pattern: Last full quarter: net buying by insiders. Insiders bought in 2 of the last 7 full quarters. On the institutional side, 105 funds reported holding EVMN at the end of Q2 2026, and more funds bought than sold.
Are insiders buying or selling EVMN stock?
In the last 12 months Evommune, Inc. insiders made open-market purchases worth about $70.2 million and sales worth about $2.3 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in EVMN?
The most recent open-market insider trade in EVMN was filed on 2026-07-10.
How many institutions own EVMN?
105 investment managers reported holding EVMN in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded EVMN?
No congressional trades in EVMN were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).